137 related articles for article (PubMed ID: 32719577)
1. Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs.
Anifowose A; Agbowuro AA; Tripathi R; Lu W; Tan C; Yang X; Wang B
Med Chem Res; 2020 Jul; 29(7):1199-1210. PubMed ID: 32719577
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core.
Tripathi R; Anifowose A; Lu W; Yang X; Wang B
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2370-2381. PubMed ID: 36043494
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogs.
Draganov AB; Yang X; Anifowose A; De La Cruz LKC; Dai C; Ni N; Chen W; De Los Santos Z; Gu L; Zhou M; Wang B
Bioorg Med Chem; 2019 Sep; 27(17):3860-3865. PubMed ID: 31324563
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of p53 through induction of MDM2 degradation: Amino acid prodrugs of anthraquinone analogs.
Anifowose A; Yuan Z; Yang X; Pan Z; Zheng Y; Zhang Z; Wang B
Bioorg Med Chem Lett; 2020 Jan; 30(2):126786. PubMed ID: 31753697
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice.
Gu L; Zhang H; Liu T; Draganov A; Yi S; Wang B; Zhou M
Mol Cancer Ther; 2018 Feb; 17(2):497-507. PubMed ID: 29282301
[TBL] [Abstract][Full Text] [Related]
6. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
[TBL] [Abstract][Full Text] [Related]
7. A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53
Skalniak L; Twarda-Clapa A; Neochoritis CG; Surmiak E; Machula M; Wisniewska A; Labuzek B; Ali AM; Krzanik S; Dubin G; Groves M; Dömling A; Holak TA
FEBS J; 2019 Apr; 286(7):1360-1374. PubMed ID: 30715803
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.
Ji C; Wang S; Chen S; He S; Jiang Y; Miao Z; Li J; Sheng C
Bioorg Med Chem; 2017 Oct; 25(20):5268-5277. PubMed ID: 28797774
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.
Shrestha JP; Fosso MY; Bearss J; Chang CW
Eur J Med Chem; 2014 Apr; 77():96-102. PubMed ID: 24631728
[TBL] [Abstract][Full Text] [Related]
10. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
11. CAPE Analogs Induce Growth Arrest and Apoptosis in Breast Cancer Cells.
Beauregard AP; Harquail J; Lassalle-Claux G; Belbraouet M; Jean-Francois J; Touaibia M; Robichaud GA
Molecules; 2015 Jul; 20(7):12576-89. PubMed ID: 26184141
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach.
Leão M; Pereira C; Bisio A; Ciribilli Y; Paiva AM; Machado N; Palmeira A; Fernandes MX; Sousa E; Pinto M; Inga A; Saraiva L
Biochem Pharmacol; 2013 May; 85(9):1234-45. PubMed ID: 23428467
[TBL] [Abstract][Full Text] [Related]
13. A metal-free DNA nuclease based on a cyclic peptide scaffold.
Alkhader S; Ezra A; Kasparkova J; Brabec V; Yavin E
Bioconjug Chem; 2010 Aug; 21(8):1425-31. PubMed ID: 20715847
[TBL] [Abstract][Full Text] [Related]
14. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
15. Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulation.
Park EJ; Choi KS; Yoo YH; Kwon TK
Anticancer Drugs; 2013 Mar; 24(3):260-9. PubMed ID: 23187459
[TBL] [Abstract][Full Text] [Related]
16. One-pot synthesis of spiro(indoline-3,4'-pyrazolo[3,4-b]pyridine)-5'-carbonitriles as p53-MDM2 interaction inhibitors.
Ibrahim HS; Eldehna WM; Fallacara AL; Ahmed ER; Ghabbour HA; Elaasser MM; Botta M; Abou-Seri SM; Abdel-Aziz HA
Future Med Chem; 2018 Dec; 10(24):2771-2789. PubMed ID: 30526032
[TBL] [Abstract][Full Text] [Related]
17. Discovery, synthesis, and biological evaluation of orally active pyrrolidone derivatives as novel inhibitors of p53-MDM2 protein-protein interaction.
Zhuang C; Miao Z; Zhu L; Dong G; Guo Z; Wang S; Zhang Y; Wu Y; Yao J; Sheng C; Zhang W
J Med Chem; 2012 Nov; 55(22):9630-42. PubMed ID: 23046248
[TBL] [Abstract][Full Text] [Related]
18. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
[TBL] [Abstract][Full Text] [Related]
19. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Discovery of Anthraquinone-Based Anticancer Agents.
Tikhomirov AS; Shtil AA; Shchekotikhin AE
Recent Pat Anticancer Drug Discov; 2018; 13(2):159-183. PubMed ID: 29210664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
